Gitesh Dubal, Executive Vice President and Chief Marketing Officer Oct. 13 | 11:00am | Oxford Biomedica Ballroom   Milwaukee, WI  (Private)  In-person Presentation  Versiti is proud to support clinical research through seamlessly integrated clinical trial capabilities, Leukopak and other human blood product provision, and central laboratory services. With over 70 years of...

Luisa Amoedo, Chief Operating Officer Oct. 11 | 3:15pm | Oxford Biomedica Ballroom  San Sebastian, Spain  (Private)  In-person Presentation  Viralgen is a CDMO born as a joint venture between AskBio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to...

Aileen Fernandes, Chief Business Officer  Oct. 11 | 5:45pm | UBC Ballroom  Gaithersburg, MD  (NASDAQ: ACLX)  In-person Presentation  Arcellx is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the forward pillars of medicine...

Dr. Jason King, Associate Director Business Development  Oct. 11 | 3:00pm | Oxford Biomedica Ballroom   Philadelphia, PA  (Private)  In-person Presentation  WuXi Advanced Therapies, a global Contract Testing Development and Manufacturing Organization (CTDMO), is the advanced therapies business unit of WuXi AppTec and offers integrated platforms to transform the discovery, development, testing,...

Evy Lundgren Åkerlund, Ph.D., CEO  Oct. 13 | 10:00am | Oxford Biomedica Ballroom  Lund, Sweden  (NASDAQ: XINT)  In-person Presentation  Xintela is a clinical-stage biopharmaceutical company developing allogeneic mesenchymal stem cell (MSC)-based therapies with a current focus on osteoarthritis (OA) and difficult-to-heal venous leg ulcers (VLU). The company’s proprietary product platform XSTEM®...

Phil Morton, Ph.D., Chief Technology Officer  Oct. 12 | 3:15pm | Oxford Biomedica Ballroom  Nottingham, UK  (Private)  In-person Presentation  Albumedix is a science-driven company and recognized leader of best-in-class albumin-enabled solutions. Established in the UK in 1984, with a mission to empower excellence, Albumedix has supported its life science partners to...

Raj Prabhakar, Senior Vice President and Chief Business Officer  Oct. 11 | 2:30pm | UBC Ballroom  New York, NY  (NASDAQ: RCKT)  In-person Presentation  Rocket Pharmaceuticals is a clinical-stage multi-platform gene therapy company focused on developing first-in-class gene therapy treatment options for rare, devastating diseases.  www.rocketpharma.com ...

Stephen Gunstream, President and CEO Oct. 12 | 5:45pm | Oxford Biomedica Ballroom   Hollister, CA  (NASDAQ: TKNO)  In-person Presentation  Teknova expedites breakthroughs in modern medicine by providing critical reagents for the production of molecular diagnostics, novel vaccines, and next-generation therapies. With a focus on quality, speed, and service, we manufacture custom...

Timothy Schroeder, Chairman and CEO Oct. 11 | 1:15pm | Oxford Biomedica Ballroom  Covington, KY  (Private)  In-person Presentation  CTI is a global research service provider delivering a full suite of services to the pharma and biotech industry. Offering manufacturing, regulatory development and strategy, clinical operations, research site, laboratory, and real-world evidence...

David Kirn, Founder and CEO  Oct. 11 | 11:30am | UBC Ballroom  Emeryville, CA  (NASDAQ: FDMT)  In-person Presentation  4D Molecular Therapeutics (4DMT) seeks to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE). TVE combines the power of directed evolution with over one billion synthetic capsid sequences...

By using this website you agree to accept our Privacy Policy and Terms & Conditions